Overview
- ACO Name and Location
- ACO Primary Contact
- Organizational Information
- Shared Savings and Losses
- Quality Performance Results
ACO Name and Location
MD Valuecare, LLC
8001 Franklin Farms Drive, Suite 130
Richmond, VA 23229
ACO Primary Contact
Shannon Lodge, ACO Administrator
8001 Franklin Farms Drive, Suite 130
Richmond VA 23229
804-306-3478
admin@mdvaluecare.com
Organizational Information
ACO Participants
“(ACO participants are not in a joint venture)”
Chickahominy Family Practice
Virginia Diabetes and Endocrinology
ACO Participants in Joint Ventures Between ACO Professionals and Hospitals
None.
ACO Governing Body
Voting Member and Vice Chair (11.11%), ACO Participant Representative, Virginia Cardiovascular Specialists
Voting Member (11.11%), ACO Participant Representative, Commonwealth Primary Care
Dr. John Kowalski
Voting Member (11.11%), ACO Participant Representative, Chickahominy Family Practice
Dr. Damian Covington
Voting Member (11.11%), ACO Participant Representative, Dominion Medical Associates
Greg Spruill
Voting Member (11.11%), Medicare Beneficiary Representative
Dr. Dave Taminger
Voting Member (11.11%), ACO Participant Representative, Commonwealth Primary Care
Dr. Steve Young
Voting Member and Board Chair (11.11%), ACO Participant Representative, Virginia Diabetes and Endocrinology
Dr. Ken Zelenak
Voting Member (11.11%), ACO Participant Representative, Commonwealth Primary Care
Dr. Shea Puttkammer
Voting Member (11.11%), ACO Participant Representative, Virginia Diabetes and Endocrinology
ACO Executive
Dr. Ken Zelenak
Medical Director
Shannon Lodge
Compliance Official
Dr. Ken Zelenak
Quality Assurance / Improvement Officer
ACO Committees and Committee Leadership
Quality Committee: Dr. Ken Zelenak, Chair
Managing Committee: Lucien Roberts, Chair
Specialist Mobilization Committee: Dr. Mark Monahan, Co-Chair and Dr. Johnny Wong, Co-Chair
Types of ACO Participants, or Combinations of Participants, that Formed the ACO
Network of individual practices of ACO professionals.
Shared Savings and Losses
Amount of Shared Savings and Losses
Third Agreement Period
- Performance Year 2020, $1,894,328
Second Agreement Period
- Performance Year 2019, $0
- Performance Year 2018, $0
- Performance Year 2017, $3,701,488
First Agreement Period
- Performance Year 2016, $1,809,663
- Performance Year 2015, $0
- Performance Year 2014, $0
How Shared Savings Are Distributed
Third Agreement Period
Performance Year 2020
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 65%
Second Agreement Period
Performance Year 2019 – N/A
Performance Year 2018 – N/A
Performance Year 2017
- Proportion invested in infrastructure: 41%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 49%
First Agreement Period
Performance Year 2016
- Proportion invested in infrastructure: 100%
- Invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 0%
Performance Year 2015 – N/A
Performance Year 2014 – N/A
Quality Performance Results
2019 Quality Performance Results:
| Measure Number | Measure Name | Your ACO Performance Rate | Current Year Mean Performance Rate (SSP ACOs) |
|---|---|---|---|
| ACO-43 | Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI #91)) * | .63 | .95 |
| ACO-13 | Falls: Screening for Future Fall Risk | 97.39 | 84.97 |
| ACO-14 | Preventive Care and Screening: Influenza Immunization | 92.82 | 76.03 |
| ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 86.49 | 81.67 |
| ACO-18 | Preventive Care and Screening: Screening for Depression and Follow-up Plan | 90.97 | 71.46 |
| ACO-19 | Colorectal Cancer Screening | 83.74 | 72.59 |
| ACO-20 | Breast Cancer Screening | 79.84 | 74.05 |
| ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 87.27 | 83.37 |
| ACO-27 | Diabetes: Hemoglobin A1c Poor Control (>9%)* | 8.90 | 14.70 |
| ACO-28 | Controlling High Blood Pressure | 78.02 | 72.87 |
*Lower score = better performance
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.